Sonda S.A. (SNSE:SONDA)

CTI BioPharma Ratios and Metrics

Market cap in millions CLP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	278,573	319,478	334,268	282,388	217,764	380,182
Market Cap Growth	-7.78%	-4.42%	18.37%	29.68%	-42.72%	-32.72%
Enterprise Value	520,965	589,976	592,519	461,568	345,340	513,958
Last Close Price	319.81	352.04	355.17	283.94	214.89	335.98
PE Ratio	8.53	10.02	8.76	7.95	6.25	827.20
Forward PE	9.36	7.87	12.18	6.57	6.20	16.80
PS Ratio	0.18	0.21	0.26	0.26	0.24	0.49
PB Ratio	0.46	0.53	0.56	0.54	0.43	0.84
P/TBV Ratio	0.88	1.01	1.14	0.93	0.74	1.45
P/FCF Ratio	2.14	6.50	26.49	9.28	4.03	5.06
P/OCF Ratio	1.84	4.40	7.62	4.82	2.53	3.12
PEG Ratio	-	3.34	3.34	3.34	3.34	3.34
EV/Sales Ratio	0.34	0.38	0.46	0.43	0.39	0.66
EV/EBITDA Ratio	4.41	5.11	5.72	4.46	3.43	6.25
EV/EBIT Ratio	6.41	6.65	7.45	6.14	4.69	10.72
EV/FCF Ratio	4.01	12.00	46.95	15.16	6.39	6.84
Debt / Equity Ratio	0.66	0.68	0.65	0.62	0.60	0.67
Debt / EBITDA Ratio	3.36	3.12	3.29	2.87	2.74	3.71
Debt / FCF Ratio	3.05	8.24	30.25	10.71	5.53	4.06
Asset Turnover	1.05	1.05	1.01	0.98	0.89	0.76
Inventory Turnover	13.57	15.21	13.53	13.54	15.98	17.13
Quick Ratio	1.33	1.29	1.17	1.43	1.59	1.86
Current Ratio	1.68	1.57	1.48	1.80	1.93	2.27
Return on Equity (ROE)	5.34%	5.50%	6.92%	7.15%	7.60%	0.36%
Return on Assets (ROA)	3.44%	3.76%	3.87%	4.31%	4.54%	2.91%
Return on Capital (ROIC)	4.93%	5.61%	5.45%	5.69%	5.89%	3.72%
Return on Capital Employed (ROCE)	8.30%	9.10%	8.80%	9.40%	9.60%	6.40%
Earnings Yield	11.73%	9.98%	11.41%	12.57%	16.01%	0.12%
FCF Yield	46.69%	15.39%	3.78%	10.78%	24.83%	19.77%
Dividend Yield	5.73%	5.20%	6.17%	7.18%	14.08%	-
Payout Ratio	41.28%	42.27%	58.21%	21.81%	79.07%	1615.54%
Buyback Yield / Dilution	-0.01%	-0.01%	0.00%	-	-	-0.01%
Total Shareholder Return	5.71%	5.19%	6.17%	7.18%	14.08%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.